showed that IL-15 produced by primary cutaneous melanoma cells, acting through “juxtacrine mechanisms”, triggers the activation of the pro-inflammatory and immune-regulatory NF-κB pathway and the modulation of class I major histocompatibility complex (MHC) molecule expression, which favors immune-escape mechanisms from cytolytic T cells (21). This evidence concerns the gene NFKB1 and melanoma.